These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 10435026

  • 1. Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction.
    Marie C, Mossiat C, Gros C, Schwartz JC, Lecomte JM, Bralet J.
    Cardiovasc Res; 1999 Mar; 41(3):544-53. PubMed ID: 10435026
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antihypertensive effects of fasidotril, a dual inhibitor of neprilysin and angiotensin-converting enzyme, in rats and humans.
    Laurent S, Boutouyrie P, Azizi M, Marie C, Gros C, Schwartz JC, Lecomte JM, Bralet J.
    Hypertension; 2000 May; 35(5):1148-53. PubMed ID: 10818079
    [Abstract] [Full Text] [Related]

  • 4. Acute natriuretic effect of fasidotrilat, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in rats with heart failure.
    Marie C, Mossiat C, Lecomte JM, Bralet J.
    Pharmacology; 1998 Jun; 56(6):291-6. PubMed ID: 9654215
    [Abstract] [Full Text] [Related]

  • 5. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    Gonzalez W, Beslot F, Laboulandine I, Fournié-Zaluski MC, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
    [Abstract] [Full Text] [Related]

  • 7. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

  • 8. Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition.
    Mellin V, Jeng AY, Monteil C, Renet S, Henry JP, Thuillez C, Mulder P.
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):390-7. PubMed ID: 16116347
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction.
    Marie C, Mossiat C, Lecomte JM, Schwartz JC, Bralet J.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1324-31. PubMed ID: 8531099
    [Abstract] [Full Text] [Related]

  • 10. Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure.
    Burrell LM, Farina NK, Balding LC, Johnston CI.
    Hypertension; 2000 Dec; 36(6):1105-11. PubMed ID: 11116133
    [Abstract] [Full Text] [Related]

  • 11. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
    Chiba K, Moriyama S, Ishigai Y, Fukuzawa A, Irie K, Shibano T.
    Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610
    [Abstract] [Full Text] [Related]

  • 12. Tissue expression of components of the renin-angiotensin system in experimental post-infarction heart failure in rats: effects of heart failure and angiotensin-converting enzyme inhibitor treatment.
    Kelly MP, Kahr O, Aalkjaer C, Cumin F, Samani NJ.
    Clin Sci (Lond); 1997 May; 92(5):455-65. PubMed ID: 9176018
    [Abstract] [Full Text] [Related]

  • 13. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
    Seeland U, Kouchi I, Zolk O, Jockenhövel F, Itter G, Linz W, Böhm M.
    Eur J Heart Fail; 2003 Jun; 5(3):241-6. PubMed ID: 12798820
    [Abstract] [Full Text] [Related]

  • 14. Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.
    Wollert KC, Studer R, von Bülow B, Drexler H.
    Circulation; 1994 Nov; 90(5):2457-67. PubMed ID: 7955203
    [Abstract] [Full Text] [Related]

  • 15. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W, Fournié-Zaluski MC, Pham I, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [Abstract] [Full Text] [Related]

  • 16. Effect on prolonged inhibition of neutral endopeptidase on cardiac hypertrophy in rats with myocardial infarction.
    Marie C, Mossiat C, Gros C, Monteil T, Bralet J.
    Cardiovasc Drugs Ther; 1996 Nov; 10(5):593-8. PubMed ID: 8950076
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC, Robl JA, Asaad MM, Bird JE, Panchal BC, Schaeffer TR, Fox M, Giancarli MR, Cheung HS.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [Abstract] [Full Text] [Related]

  • 18. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
    de Resende MM, Mill JG.
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive and antihypertrophic effects of omapatrilat in SHR.
    Burrell LM, Droogh J, Man in't Veld O, Rockell MD, Farina NK, Johnston CI.
    Am J Hypertens; 2000 Oct; 13(10):1110-6. PubMed ID: 11041166
    [Abstract] [Full Text] [Related]

  • 20. Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.
    Huang H, Arnal JF, Llorens-Cortes C, Challah M, Alhenc-Gelas F, Corvol P, Michel JB.
    Circ Res; 1994 Sep; 75(3):454-61. PubMed ID: 8062419
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.